This website is written by experts in Pharmaceutical Industry Manufacturing Research and Development and Regulatory Affairs Since 2008 and in 2011 Awarded as one of top 10 websites across world in Pharmaceutical Manufacturing Regulatory
USFDA WHO GMP Guidelines Pharmaceutical Regulations Information about Pharma Quality Managment System Validations Process Validation Cleaning Validation Equipment Qualification Equipment Process Validation Computer System Validation Sterile Product Manufacturing Guidelines Media fill guideline Aseptic Techniques in Sterile dosage form Clean Room Clean Room Classification Guidelines on Area Qualification HVAC AHU HEPA Filter HEPA Filter integrity testing and leak test

Wednesday, June 22, 2011

New biomarker identified which is linked to increased risk of kidney failure.

It will be possible to predict if a patient will get kidney failure in future and precautions can be taken to reduce the load on kidney along with hemodialysis.

It will be possible now to predict early if an patient is going to get a kidney failure in future or not, and if patient is found to be at high risk of getting kidney failure then doctors can set him on dietary control to reduce level of phosphate and dialysis and bring back health improvement which may help in controlling the worsening of the condition, this could be possible in few days from now.

As the researchers from National Institute of Diabetes and Digestive Diseases and Kidney Diseases (NIDDK) at the National Institute from health (NIH) USA University of Miami, have identified a hormone which regulates the phosphate in our body, The increased level of this hormone is associated with increased risk of getting kidney failure.
The hormone identified is called hormone fibroblast growth factor 23 (FGF23) which was found as higher as 6 times than the normal individuals , the increased level of hormone fibroblast growth factor 23 (FGF23) almost doubles the risk of kidney failure in patients with baseline glomerular filtration rate (eGFR) is 45 milliliters or higher .
Scientists are hopeful about developing a drug or a treatment for reducing the phosphate level from the gut and hormone fibroblast growth factor 23 (FGF23) which is responsible for worsening the condition in chronic kidney disease (CKD) patients.
Early earlier diagnosis of increased phosphate can be treated by controlling diet which restricts dietary intake of phosphates.
The phosphates are important building elements of our bone and are utilized to store food energy which will be utilised readily for bringing about biochemical reactions in our body and as a resources of energy rich molecules and are important constituents of nucleic acids DNA and RNA.
Increased blood phosphate level puts load on kidney and damages them over the period.a detailed out come of clinical study  is published on the NIH website.

Renin and Angiotensin System

No comments:

Pharma Guidelines Most Read

.

Readers Visit Number

This website is Authentic Source of Pharmaceutical Guidelines

This website is Authentic Source of Pharmaceutical Guidelines

Pharma Validations Quality Management System USFDA Guidelines WHO GMP Guidelines New Drug Update





This website consist of detail Information about Pharma Guidelines Pharma Regulatory Affairs USFDA Guidelines WHO Guidelines Pharmaceutical Quality Management System Pharma Validations Process Validation Cleaning Validation Equipment Qualification Equipment Process Validation Computer System Validation Sterile Product Manufacturing Guidelines Media fill guideline Aseptic Techniques in Sterile dosage form Clean Room Clean Room Classification Guidelines on Area Qualification HVAC AHU HEPA Filter HEPA Filter integrity testing and leak test